Alnylam Pharmaceuticals (NASDAQ:ALNY) is scheduled to announce Q1 earnings results on Thursday, May 2nd, before market open. The consensus EPS Estimate is -$0.48 (+54.7% Y/Y) and the consensus Revenue...
Source LinkAlnylam Pharmaceuticals (NASDAQ:ALNY) is scheduled to announce Q1 earnings results on Thursday, May 2nd, before market open. The consensus EPS Estimate is -$0.48 (+54.7% Y/Y) and the consensus Revenue...
Source Link
Comments